Home > Case Studies, Magnetic Therapy > The skyrocketing cost of rheumatoid arthritis drugs

The skyrocketing cost of rheumatoid arthritis drugs

A growing challenge for the Australian health system is the growing cost of the Pharmaceutical Benefits Scheme (PBS) which subsidises the costs of approved drugs.

Rheumatoid arthritis is an autoimmune disease which causes chronic inflammation of the joints and as an example,  the annual cost of these drugs to the Australian tax payer increased three-fold from about $46 million to almost $134 million between 2003 and 2007. Clearly this is unsustainable.

Lifestyle Therapies offers drug free treatments such as neuromagnetic therapy that can dramatically reduce the costs and the side effects on your body. In fact, this case study presented by principal physiotherapist, Dianne Hermans at an International Physiotherapy Conference showed a gradual decrease in pain medication of over $700 per year to almost nothing after a 20 year chronic pain history.

Reduction in cost of pain medication

Categories: Case Studies, Magnetic Therapy Tags:
You must be logged in to post a comment.